Results
2734
Stocks with high levels of insider buying the past 3 months and good analyst coverage.
2,734 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
JNJ | US$142.06 | -1.5% | -12.5% | US$342.0b | US$171.61 | PE23.2x | E9.3% | 3.5% | Pharmaceuticals & Biotech | ||
AZN | UK£109.82 | 2.5% | 1.2% | UK£170.3b | UK£143.54 | PE32x | E16.8% | 2.1% | Pharmaceuticals & Biotech | ||
HSBA | UK£7.99 | 1.9% | 34.0% | UK£140.7b | UK£8.74 | PB0.9x | E-1.2% | 6.3% | Banks | ||
CBA | AU$156.05 | 0.7% | 37.3% | AU$260.9b | AU$99.32 | PB3.6x | E4.4% | 3.0% | Banks | ||
PFE | US$26.72 | 0.5% | -6.9% | US$151.4b | US$31.78 | PE35.4x | E9.1% | 6.4% | Pharmaceuticals & Biotech | ||
LOW | US$247.90 | -0.2% | 13.2% | US$140.0b | US$282.83 | PE20.5x | E5.9% | 1.9% | Retail | ||
COP | US$101.92 | 0.8% | -8.8% | US$131.8b | US$132.79 | PE13.3x | E2.2% | 3.6% | Energy | ||
BHP | AU$39.68 | -0.2% | -16.8% | AU$201.3b | AU$46.74 | PE15.7x | E5.9% | 6.0% | Materials | ||
TD | CA$78.20 | 0.5% | -2.8% | CA$136.9b | CA$84.36 | PB1.2x | E14.5% | 5.4% | Banks | ||
BREN | Rp10,450.00 | 8.0% | 122.3% | Rp1398.1t | n/a | PE792.5x | n/a | 0.04% | Utilities | ||
BP. | UK£4.25 | 4.2% | -6.4% | UK£67.2b | UK£5.00 | PE30.2x | E24.1% | 5.9% | Energy | ||
INVE A | SEK 299.40 | 0.8% | 30.2% | SEK 917.0b | SEK 303.50 | PE4.5x | E-55.0% | 1.6% | Diversified Financials | ||
ATCO A | SEK 175.65 | 2.3% | 6.4% | SEK 827.1b | SEK 189.52 | PE29.8x | E7.4% | 1.6% | Capital Goods | ||
1299 | HK$52.60 | -5.2% | -17.1% | HK$564.8b | HK$93.17 | PE15x | E13.7% | 3.1% | Insurance | ||
ITW | US$244.90 | -2.9% | -3.4% | US$72.3b | US$264.94 | PE20.9x | E1.0% | 2.5% | Capital Goods | ||
NAB | AU$37.95 | 1.1% | 22.8% | AU$116.4b | AU$33.53 | PB1.9x | E2.1% | 4.5% | Banks | ||
WBC | AU$32.60 | -0.1% | 40.6% | AU$111.8b | AU$28.32 | PB1.6x | E-0.03% | 4.7% | Banks | ||
GSK | UK£13.50 | 0% | -14.6% | UK£55.1b | UK£18.17 | PE21.9x | E20.4% | 4.3% | Pharmaceuticals & Biotech | ||
DGE | UK£24.47 | -2.3% | -12.8% | UK£54.4b | UK£27.32 | PE17.2x | E3.8% | 3.5% | Food, Beverage & Tobacco | ||
FDX | US$270.73 | -1.3% | 8.9% | US$65.2b | US$325.95 | PE16.8x | E13.4% | 2.0% | Transportation | ||
SPG | US$170.96 | -2.9% | 16.6% | US$64.2b | US$186.03 | PB20.9x | E0.6% | 4.9% | Real Estate | ||
CNR | CA$144.15 | -2.7% | -14.8% | CA$90.6b | CA$172.86 | PE16.7x | E4.2% | 2.3% | Transportation | ||
CRH | US$91.78 | -1.6% | 33.7% | US$62.2b | US$113.33 | PE18x | E9.1% | 1.5% | Materials | ||
CPG | UK£26.97 | 1.2% | 23.8% | UK£45.8b | UK£27.05 | PE39.8x | E14.8% | 1.8% | Consumer Services |